What Researchers Did
Researchers examined the outcomes of 7 patients who received hyperbaric oxygen therapy (HBOT) as an additional treatment after undergoing surgery to repair bladder fistulas.
What They Found
All 7 patients, including 6 with vesicovaginal fistula and 1 with colovesical fistula, received HBOT once daily for 10 consecutive days starting on the first postoperative day. No patients experienced any adverse reactions during the HBOT course, and all achieved an uneventful recovery with no recurrence of symptoms observed during 3-12 months of follow-up.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small case report involving only 7 patients, which limits the generalizability of its findings.